ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis.
Elisabetta MaidaMarcello MocciaRaffaele PalladinoGiovanna BorrielloGiuseppina AffinitoMarinella ClericoAnna Maria RepiceAlessia Di SapioRosa IodiceAntonio Luca SpieziaMaddalena SparacoGiuseppina MieleFloriana BileCristiano ScandurraDiana FerraroMaria Laura StromilloRenato DocimoAntonio De MartinoLuca MancinelliGianmarco AbbadessaKrzysztof SmolikLorenzo LorussoMaurizio LeoneElisa LeveraroFrancesca LauroFrancesca TrojsiLidia Mislin StreitoFrancesca GabrieleFabiana MarinelliAntonio IannielloFederica De SantisMatteo FoschiNicola De StefanoVincenzo Brescia MorraAlvino BiseccoGiancarlo CogheEleonora CoccoMichele RomoliFrancesco CoreaLetizia LeocaniJessica FrauSimona SaccoMatilde IngleseAntonio CarotenutoRoberta LanzilloAlessandro PadovaniMaria TriassiSimona BonavitaLuigi Lavorgnanull nullPublished in: Journal of neurology (2024)
ChatGPT-authored responses provided higher empathy than neurologists. Although AI holds potential, physicians should prepare to interact with increasingly digitized patients and guide them on responsible AI use. Future development should consider tailoring AIs' responses to individual characteristics. Within the progressive digitalization of the population, ChatGPT could emerge as a helpful support in healthcare management rather than an alternative.
Keyphrases
- multiple sclerosis
- healthcare
- end stage renal disease
- artificial intelligence
- physical activity
- newly diagnosed
- ejection fraction
- primary care
- chronic kidney disease
- depressive symptoms
- mental health
- peritoneal dialysis
- machine learning
- patient reported outcomes
- white matter
- risk factors
- risk assessment
- current status